척추 비고정 장치 시장 규모는 2024년에 40억 8,000만 달러로 평가되었고, 2026-2032년 연평균 4.24% 성장하여 2032년에는 56억 8,000만 달러에 달할 것으로 예측됩니다.
척추 비고정 장치는 척추를 고정하는 고정술과 달리 척추 비고정 장치는 퇴행성 디스크 질환, 척추관 협착증, 기타 척추 질환을 치료하면서 척추의 움직임과 유연성을 유지하도록 하는 것을 목표로 합니다. 척추의 움직임과 유연성을 유지하는 것을 목적으로 합니다.
척추 비고정 장치 시장은 척추관 협착증, 퇴행성 추간판 질환 등 척추 질환의 빈도가 증가함에 따라 시장이 확대되고 있습니다.
척추 임플란트는 환자의 척추를 안정시키고 활성화시킬 뿐만 아니라 척추의 불균형을 교정하는 데에도 사용됩니다. 이러한 기구들은 일반적으로 척추 고정 장치와 척추 비고정 장치로 분류됩니다. 비고정 기술을 척추 수술에 도입함으로써 환자가 척추를 움직이거나 늘릴 수 있게 되어 치료 성적이 향상되었습니다.
세계보건기구(WHO)에 따르면, 요통은 어린이부터 노인까지 연령에 관계없이 모든 사람에게 영향을 미치며, 의료기관을 찾는 가장 흔한 이유 중 하나입니다. 요통의 발생률을 추정하는 것은 어렵습니다. 왜냐하면 요통은 성인이 되었을 때 이미 매우 흔한 증상이며, 그 증상은 계속 반복될 가능성이 높기 때문입니다. 비특이적(일반적인) 요통은 선진국에서는 평생 동안 60-70%의 사람들이 겪을 것으로 예측됩니다.
세계 척추 비고정 장치 시장을 형성하는 주요 시장 역학은 다음과 같습니다.
주요 시장 성장 촉진요인:
최소침습수술(MIS) 치료에 대한 수요 증가: MIS 기술은 표준 개복수술보다 절개창이 작고, 출혈이 적고, 회복이 빠르며, 불편함이 적습니다. 척추 비고정 장치는 MIS 치료에 적합한 경우가 많으며, 외과 의사와 환자 모두에게 매력적일 수 있습니다.
고령화 인구의 확대: 전 세계 인구는 고령화되고 있으며, 나이가 들수록 디스크 퇴행성 질환이나 척추관 협착증과 같은 척추 질환이 발생하기 쉽습니다. 이러한 문제들은 통증과 뻣뻣함, 움직임의 장애로 이어집니다. 척추 비고정 장치는 노인의 증상을 완화하고 이동성을 유지하는 데 도움이 될 수 있습니다.
결과와 삶의 질에 초점을 맞추다: 환자 보고에 의한 결과와 삶의 질 지표는 의료에서 점점 더 중요해지고 있습니다. 척추 비고정 장치는 통증과 기능 장애를 완화할 뿐만 아니라 척추의 움직임과 기능을 유지함으로써 환자의 전반적인 삶의 질을 유지하거나 향상시키는 것을 목표로 합니다.
최소침습적 접근법: 많은 비고정 수술은 최소침습적 수술로 시행할 수 있으며, 절개창이 작고 출혈이 적으며 회복이 빠르다는 장점이 있습니다. 최소 침습 수술이 점점 더 대중화됨에 따라 이러한 수술에 대응하는 척추 비고정 장치에 대한 수요가 증가하고 있습니다.
주요 과제
외과의사 교육 및 채용: 척추 비고정 장치를 적절히 삽입하기 위해서는 전문적인 훈련과 기술이 필요한 경우가 많습니다. 외과의사는 수술 기술에 익숙하지 않거나 학습 곡선이 가파르다고 느끼면 이러한 기구를 사용하는 것을 주저할 수 있습니다. 외과 의사의 교육 및 훈련 프로그램을 개선함으로써 이 문제를 해결하고 척추 비고정 장치의 사용을 확대할 수 있습니다.
장기 임상 증거: 척추 비고정 장치에 대한 임상 연구는 긍정적인 결과를 보였지만, 안전성, 유효성, 내구성에 대한 장기적인 데이터가 더 많이 필요합니다. 장기적인 임상 데이터는 규제 승인을 받고, 지불을 확보하고, 이러한 기술의 장기적인 이점에 대한 환자와 의료 서비스 제공업체의 신뢰를 얻기 위해 필수적입니다.
규제 과제: 비고정형 의료기기의 규제 프로세스는 복잡하고 시간이 오래 걸립니다. 따라서 새로운 기기의 개발 및 상용화가 지연될 수 있습니다.
주요 동향 :
노령 인구 증가: 세계 인구의 고령화에 따라 척추 질환을 앓고 있는 사람이 늘어날 가능성이 높습니다. 큰 수술에 따른 위험을 감당할 수 없는 노년층에게는 비고정 장치가 적절한 선택이 될 수 있습니다.
치료 결과와 비용 효율성에 대한 중요성: 전 세계 의료 시스템은 가치에 기반한 의료 서비스를 제공하고 의료 비용을 절감하는 데 점점 더 중점을 두고 있습니다. 척추 비고정 장치는 특히 입원 기간 단축, 재수술률 감소, 장기적인 환자 만족도 향상 등의 측면에서 표준 고정 수술보다 임상 결과를 개선하고 비용을 절감할 수 있습니다.
척추 질환에 대한 인식 증가: 척추관 협착증, 추간판 퇴행성 질환 등 척추 질환에 대한 인식이 높아지고 있습니다. 이에 따라 이들 질환에 대한 치료를 원하는 사람들이 증가하고 있으며, 비고정형 척추 치료 장비에 대한 수요가 증가하고 있습니다.
움직임 유지에 대한 관심 증가: 척추 고정술은 환자의 운동 범위를 좁힐 수 있습니다. 비고정 장치는 척추의 움직임을 유지하는 것을 목표로 하며, 그 결과 환자의 장기적인 결과를 개선할 수 있습니다.
Non-fusion Spinal Devices Market size was valued at USD 4.08 Billion in 2024 and is projected to reach USD 5.68 Billion by 2032, growing at a CAGR of 4.24% from 2026 to 2032.
Non-fusion spinal devices are medical devices used to treat a variety of spine diseases that do not require vertebral segment fusion. Unlike fusion operations, which join two or more vertebrae together to immobilize the spine, non-fusion devices aim to maintain motion and flexibility in the spine while treating degenerative disc disease, spinal stenosis, and other spinal conditions.
The non-fusion spinal devices market is expanding due to the increasing frequency of spinal illnesses such as spinal stenosis and degenerative disc disease.
Spinal implants are used to stabilize and revitalize patients' spines, as well as to right spinal disproportions. These devices are generically categorized as fusion or non-fusion spinal devices. Integrating non-fusion technologies into spinal surgery has improved outcomes by allowing patients to move and stretch their spines.
According to the WHO, back pain affects everyone, regardless of age, from children to the elderly, and is a common reason for medical visits. It is difficult to estimate the incidence of back pain because it is already extremely common by the time a person reaches adulthood, and the symptoms are likely to repeat throughout time. Non-specific (common) back pain is expected to affect 60% to 70% of people in industrialized countries over their lifespan.
The key market dynamics that are shaping the global non-fusion spinal device market include:
Key Market Drivers:
Increasing Demand for Minimally Invasive Surgery (MIS) Treatments: MIS techniques are associated with smaller incisions, less blood loss, faster recovery times, and less discomfort than standard open operations. Non-fusion spinal devices are frequently well-suited for MIS treatments, boosting their appeal to both surgeons and patients.
Expanding Aging Population: The global population is aging, and as people get older, they are more susceptible to developing spine diseases such as degenerative disc degeneration and spinal stenosis. These problems can lead to pain, stiffness, and trouble moving. Non-fusion spinal devices can help relieve symptoms and maintain mobility in older persons.
Focus on Outcomes and Quality of Life: Patient-reported outcomes and quality of life metrics are becoming increasingly important in healthcare. Non-fusion spinal devices are intended not just to relieve pain and dysfunction, but also to maintain or improve patients' overall quality of life by maintaining spinal motion and function.
Minimally Invasive Approaches: Many non-fusion operations can be performed with minimally invasive techniques, which have advantages such as smaller incisions, less blood loss, and faster recovery times. As minimally invasive procedures become increasingly popular, there is a greater demand for non-fusion spinal devices that work with these techniques.
Key Challenges:
Surgeon Training and Adoption: Non-fusion spinal devices frequently necessitate specialized training and skill to properly implant. Surgeons may be hesitant to use these devices if they are unfamiliar with the surgical techniques or see a steep learning curve. Improving surgeon education and training programs can help to address this issue and enable greater utilization of non-fusion spinal devices.
Long-Term Clinical Evidence: While clinical studies on non-fusion spinal devices have provided positive results, more long-term data on their safety, efficacy, and durability are required. Long-term clinical data is critical for obtaining regulatory clearance, securing payment, and instilling patient and healthcare provider confidence in these technologies' long-term advantages.
Regulatory Challenges: The regulation process for non-fusion devices can be complicated and time-consuming. This might cause delays in the development and commercialization of new devices.
Key Trends:
Growing Geriatric Population: As the world's population ages, more people are likely to have spine disorders. Non-fusion devices may be an appropriate choice for older individuals who are unable to fight the risks involved with major surgery.
Focus on Outcomes and Cost-Effectiveness: Healthcare systems around the world are increasingly focused on providing value-based care and reducing healthcare costs. Non-fusion spinal devices have the potential to improve clinical outcomes and cost savings over standard fusion surgeries, particularly in terms of shorter hospital stays, lower rates of revision surgery, and better long-term patient satisfaction.
Growing Awareness of Spinal Disorders: There is a growing awareness of spinal disorders, such as spinal stenosis and disc degeneration. This is leading to more people seeking treatment for these conditions, which is driving up the demand for non-fusion spinal devices.
Increasing Focus on Motion Preservation: Spinal fusion surgery might reduce a patient's range of motion. Non-fusion devices aim to maintain motion in the spine, which can result in better long-term outcomes for patients.
Here is a more detailed regional analysis of the global non-fusion spinal device market:
North America:
The benefits of non-fusion spinal devices corresponds in North America have seen a quick adoption of modern medical technology, particularly non-fusion spinal devices, because of variables such as high healthcare spending, a robust research and development infrastructure, and a strong demand for new treatment choices. Patients and healthcare providers in the region are increasingly embracing minimally invasive procedures that enable quicker recovery periods and better outcomes.
Government activities and policies in North America have contributed significantly to the introduction of non-fusion spinal devices. Efforts to improve the quality of life for people suffering from spinal problems have resulted in increasing funding for R&D and healthcare infrastructure. Furthermore, regulatory authorities such as the FDA in the United States have simplified the approval procedure for these devices, enabling fast market access and encouraging innovation in the industry.
Overall, a favorable regulatory environment, innovations in technology, and government assistance have pushed North America to the forefront of the spinal non-fusion device market. As the region continues to prioritize healthcare innovation and quality improvement measures, its dominance in this industry is projected to last for the foreseeable future.
Asia Pacific:
The Asia Pacific area offers promising market opportunities for spinal non-fusion devices, due to factors such as rising awareness of healthy living, growth of medical facilities, and a significant increase in elderly people. With an increasing emphasis on preventative healthcare and greater access to medical services throughout the region, people are becoming more aware of the necessity of preserving spinal health. This increased knowledge, combined with a rise in healthcare infrastructure development, presents a favorable climate for the adoption of innovative spinal treatment options, such as non-fusion devices.
Furthermore, the Asia Pacific region is undergoing a large demographic shift, with a substantial increase in aged people. According to the United Nations Economic and Social Commission for Asia and the Pacific demographic statistics sheet from 2016, 12.4% of the region's population was 60 years or older, a proportion that is anticipated to rise even higher by 2050.
This demographic trend highlights the increased demand for innovative solutions to age-related spinal disorders, which is driving the regional non-fusion spinal device market. As Asia Pacific's healthcare systems modernize and focus on meeting the demands of an aging population, the market for spinal non-fusion devices is expected to rise significantly.
The Global Non-fusion Spinal Device Market is Segmented on the basis of Type, Application, And Geography.
Based on the Component, the market is bifurcated into Artificial Discs Replacement, Dynamic Stabilization Devices and Annulus Repair Devices. Growing markets in the non-fusion spinal device sector. It's difficult to say for certain which is growing the fastest, but annulus repair devices are a relatively new technology that may be enjoying the fastest growth due to an increased emphasis on motion preservation methodologies.
Based on Application, the market is segmented into Hospitals and Ambulatory Surgical Centers. However, Ambulatory Surgical Centers are predicted to increase quicker due to the growing preference for minimally invasive treatments and outpatient care. These operations are less expensive and require shorter recovery times, making ASCs a more appealing alternative for both patients and insurance.
The "Global Non-fusion Spinal Device Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Centinel Spine, LLC, B. Braun Melsungen, Johnson & Johnson, Medtronic PLC, Pioneer Surgical Technologies, Synthes Holding AG, Depuy Spine, Globus Medical Inc., and NuVasive, Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.